News
Stay up to date on the latest crypto trends with our expert, in-depth coverage.
Salvo Games Joins Manadia to Accelerate AI-Driven Web3 Gaming
BlockchainReporter·2026/02/15 12:00
How Itron (ITRI) Will Use AI To Reduce Wildfire Risks
Finviz·2026/02/15 11:54
GE HealthCare Technologies Inc. (GEHC) Expands Healthcare Technology Offerings
Finviz·2026/02/15 11:54
DexCom Inc. (DXCM) Reports Strong Performance While Maintaining Forward Outlook
Finviz·2026/02/15 11:54
The hidden infrastructure crisis in mortgage and real estate finance that only tokenization can solve | Opinion
Crypto.News·2026/02/15 11:51
Litecoin Closes Bullish — $57 Break Could Ignite Next Leg Up
CryptoNewsNet·2026/02/15 11:48
XRP Price Prediction: Ripple Eyes $1.50 Breakthrough After 4% Daily Jump
CryptoNewsNet·2026/02/15 11:48
Memecoin Market May Be Breaking Down, Santiment Warns
Newsbtc·2026/02/15 11:40
5 Best Cryptos to Buy Now for the Next Bounce: Oversold + Discount Prices (February 2026)
BlockchainReporter·2026/02/15 11:21
Your heating expenses could render you 'stunned' following the Arctic cold snap
101 finance·2026/02/15 11:18
Flash
13:39
BTC current market dominance drops to 51.14%BTC declined, with a trading volume of $28.7 billions in the past 24 hours, a circulating market capitalization of $1.35 trillions, and a market share decrease of 0.49%. Data is for reference only.
13:31
Medtronic Q3 revenue up 8.7% year-on-year, full-year adjusted EPS guidance below expectationsGlonghui, February 17th｜Medical device manufacturer Medtronic announced its fiscal year 2026 third quarter results, with revenue increasing by 8.7% year-on-year to $9.0 billion, exceeding market expectations by $110 million; adjusted earnings per share were $1.36, surpassing market expectations by $0.02. The company reaffirmed its fiscal year 2026 organic revenue growth forecast of approximately 5.5%, and its adjusted earnings per share forecast of $5.62 to $5.66, which is below the market consensus of $6.12.
13:22
Disc Medicine executives noted during a conference call that the policy debate over accelerated approval pathways has spanned multiple government administrations.Recent decisions by regulatory authorities indicate that their assessment of the criteria for accelerated approval is becoming "increasingly stringent."